Sunday, 22 Mar 2026
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • ScienceAlert
  • VIDEO
  • White
  • man
  • Trumps
  • Season
  • star
  • Watch
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Kleiner Perkins is having a very good week
Tech and Science

Kleiner Perkins is having a very good week

Last updated: August 1, 2025 10:30 pm
Share
Kleiner Perkins is having a very good week
SHARE

The Week of Tech IPOs: Figma and Ambiq Micro

As the tech industry continues to buzz about Figma’s successful IPO, another notable tech company, Ambiq Micro, made its debut on the stock market this week. Ambiq Micro, a chip maker specializing in wearable devices, saw its shares surge from an initial price of $24 to over $42 by the end of the week.

Interestingly, both Figma and Ambiq Micro share a common investor: Kleiner Perkins, a prominent venture capital firm. This week has undoubtedly been a lucrative one for Kleiner Perkins, with substantial gains from both companies.

Let’s delve into the specifics of Kleiner Perkins’ investments in Figma and Ambiq Micro:

Investment in Figma

Kleiner Perkins sold 1,346,499 shares of Figma at the IPO price of $33 per share, with the potential to sell up to 2,756,020 shares if additional shares were exercised by bankers. The demand for Figma’s shares far exceeded supply, leading us to assume that the full tranche was snapped up.

Currently, Kleiner Perkins still holds 52,364,374 shares of Figma. With share prices fluctuating between $110 and over $142, we’ll consider the closing price of $115 for our calculations.

For Figma, Kleiner Perkins realized an estimated $91 million from share sales, with a remaining stake valued at over $6 billion. This stake alone surpasses the firm’s last mega-funds raised in 2024, totaling $2 billion across two vehicles. Mamoon Hamid, a Kleiner Perkins partner and Figma board member, oversaw the investment in Figma.

Investment in Ambiq Micro

Ambiq Micro, a smaller company compared to Figma, conducted a modest IPO, selling 4 million shares and raising $96 million. Kleiner Perkins holds 2,081,831 shares in Ambiq Micro, with shares trading at $43.85 as of Friday.

See also  Vibrio pectenicida Identified as Cause of Sea Star Wasting Disease Affecting Billions

Kleiner Perkins’ stake in Ambiq Micro amounts to $91.3 million (2,081,831 shares at $43.85). The firm’s successful investments in both Figma and Ambiq Micro reflect a profitable week for Kleiner Perkins.

Additional Successes for Kleiner Perkins

Aside from Figma and Ambiq Micro, Kleiner Perkins has seen further successes in the tech industry. The firm reportedly enjoyed a significant return from Google’s deal to license technology from Windsurf and hire its top talent. Additionally, Fleet tracking startup Motive Technologies, backed by Kleiner Perkins, raised $150 million this week, signaling potential for an upcoming IPO in 2025.

Kleiner Perkins’ impressive track record in the tech sector underscores its prowess as a leading venture capital firm, with successful investments contributing to its continued growth and success.

TAGGED:goodKleinerPerkinsWeek
Share This Article
Twitter Email Copy Link Print
Previous Article There’s Plenty Of Water On Mars For Future Colonists There’s Plenty Of Water On Mars For Future Colonists
Next Article Collagen Decline Affects More Than Just Your Skin Collagen Decline Affects More Than Just Your Skin
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Whitecaps food poisoning drama: Canada’s Jesse Marsch urges Concacaf action after players fall ill in Mexico

The Vancouver Whitecaps were forced to cancel training after several players and staff members fell…

June 6, 2025

Paramount+ Commissions Australian Series ‘Playing Gracie Darling’

Paramount+ has announced a new mystery drama series titled "Playing Gracie Darling," which revolves around…

September 18, 2024

Dinesh Karthik hosts entire team at his Chennai residence ahead of CSK vs RCB IPL 2025 match [Watch]

The Royal Challengers Bengaluru (RCB) team recently gathered at the residence of their batting coach,…

April 1, 2025

How Cofertility Is Changing Egg Donation Pay And The IVF Process

In today's society, the fertility industry has become a booming business, with more women than…

October 26, 2024

Tiger Woods’ Former Mistress Rachel Uchitel Is Married

Rachel Uchitel Tiger Woods' Former Mistress Ties the Knot!!! Published January 1, 2026 5:49 PM…

January 1, 2026

You Might Also Like

How stress causes an eczema flare up
Tech and Science

How stress causes an eczema flare up

March 22, 2026
Are AI tokens the new signing bonus or just a cost of doing business?
Tech and Science

Are AI tokens the new signing bonus or just a cost of doing business?

March 22, 2026
Major leap towards reanimation after death as mammal’s brain preserved
Tech and Science

Major leap towards reanimation after death as mammal’s brain preserved

March 22, 2026
Is Salesforce a good long-term investment? Its buy-and-hold prospects explained
Economy

Is Salesforce a good long-term investment? Its buy-and-hold prospects explained

March 21, 2026
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?